Masahiro Morita

Prof. Dr. Masahiro Morita

Department of Molecular Medicine, UT Health Science Center San Antonio, San Antonio, TX 78229, USA
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in Cell Metabolism
Verified
Journal Article
Closed access
MMMasahiro Morita
Masahiro Morita
SGSimon-Pierre Gravel
Simon-Pierre Gravel
VCValérie Chénard
Valérie Chénard
KSKristina Sikström
Kristina Sikström
LZLiang Zheng
Liang Zheng
NSNahum Sonenberg
Nahum Sonenberg

16 February 2015 in Cell Cycle
Verified
Journal Article
Open access
MMMasahiro Morita
Masahiro Morita
SGSimon-Pierre Gravel
Simon-Pierre Gravel
LHLaura Hulea
Laura Hulea
OLOla Larsson
Ola Larsson
MPMichael Pollak
Michael Pollak
ITIvan Topisirovic
Ivan Topisirovic
Protein synthesis is one of the most energy consuming processes in the cell. The mammalian/mechanistic target of rapamycin (mTOR) is a serine/threonine kinase that integrates a multitude of extrace...

1 September 2017 in Molecular Cell
Verified
Journal Article
Closed access
MMMasahiro Morita
Masahiro Morita
JPJulien Prudent
Julien Prudent
KBKaustuv Basu
Kaustuv Basu
VGVanessa Goyon
Vanessa Goyon
SKSakie Katsumura
Sakie Katsumura
NSNahum Sonenberg
Nahum Sonenberg

1 June 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
BFBruno D. Fonseca
Bruno D. Fonseca
CZChadi Zakaria
Chadi Zakaria
JJJian-Jun Jia
Jian-Jun Jia
TGTyson E. Graber
Tyson E. Graber
YSYuri Svitkin
Yuri Svitkin
CDChristian Damgaard
Christian Damgaard
The mammalian target of rapamycin complex 1 (mTORC1) is a critical regulator of protein synthesis. The best-studied targets of mTORC1 in translation are the eukaryotic initiation factor binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1). In this study, we identify the La related protein 1 (LARP1) as a key novel target of mTORC1 with a fundamental role in terminal oligopyrimidine (TOP) mRNA translation. Recent genome-wide studies indicate that TOP and TOP-like mRNAs comprise a large portion of the mTORC1 translatome, but the mechanism by which mTORC1 controls TOP mRNA translation is incompletely understood. Here, we report that LARP1 functions as a key repressor of TOP mRNA translation downstream of mTORC1. Our data show that: (i) LARP1 associates with mTORC1 via RAPTOR, (ii) LARP1 interacts with TOP mRNAs in an mTORC1-dependent manner, (iii) LARP1 binds the 5'TOP motif to repress TOP mRNA translation, and (iv) LARP1 competes with the eukaryotic initiation factor (eIF) 4G for TOP mRNA binding. Importantly, from a drug resistance stand-point, our data also show that (v) reducing LARP1 protein levels by RNA interference attenuates the inhibitory effect of rapamycin, Torin1 and amino acid deprivation on TOP mRNA translation. Collectively, our findings demonstrate that LARP1 functions as an important repressor of TOP mRNA translation downstream of mTORC1.

7 October 2011 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
MFMarc R Fabian
Marc R Fabian
MCMaja K Cieplak
Maja K Cieplak
FFFilipp Frank
Filipp Frank
MMMasahiro Morita
Masahiro Morita
JGJonathan Green
Jonathan Green
NSNahum Sonenberg
Nahum Sonenberg

1 August 1993 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
NTNoriaki Takeda
Noriaki Takeda
SHSatoshi Hasegawa
Satoshi Hasegawa
MMMasahiro Morita
Masahiro Morita
TMTORU MATSUNAGA
TORU MATSUNAGA